Novo Nordisk A/S Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (45)

Latest Posts

About This Stock More About This Stock
E Sh-tdown To End
Article By: Vivian Lewis
Monday, January 22, 2018 12:15 PM EST
News today from Bermuda, Brazil, Britain, Canada, Chile, China, Colombia, Denmark, Dutch Antilles, France, Finland, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Panama, Sweden, Switzerland, and the USA where the sh-tdown is being ended.
In this article: AIG, CEA, SLFPY, NTR, BLX, BP, EONGY, SLB, EC, DGRLY, AGU, CB, CZZ, SQM, VR, XYL, PPEHF, SNY, TEVA, NVO, SHPG, MZOR, SANM, NOK, TCEHY, SAN, TCTZF, DCM, MXE, CTY Also: AMZN
Read
3 Large-Cap Pharma Stocks To Watch Out For This New Year
Article By: Zacks Investment Research
Friday, January 5, 2018 4:35 AM EST
The year 2017 has turned out to be pretty impressive for the pharma/biotech stocks.
In this article: NVO, RHHBY, ABBV Also: AMGN
Read
4 Large-Cap Pharma Stocks That Outperformed The S&P This Year
Article By: Zacks Investment Research
Sunday, December 31, 2017 2:53 PM EST
Upbeat quarterly results, rise in demand on new product sales, successful innovation and product line expansion, strong clinical study results as well as strong performance of legacy products propelled the large-cap drug sector to new highs in 2017.
In this article: AZN, JNJ, NVO, ABBV Also: RHHBY
Read
Week In Review: Another Billion Dollar Week For China Life Science Deals
Article By: ChinaBio® Today
Saturday, September 30, 2017 5:55 PM EST
Shanghai Pharma Holding (SHA: 601607) may acquire part of Alvogen -- possibly Alvogen's US operations -- according to Bloomberg. Alvogen is a US-based generic drug maker thought to be worth as much as $4 billion.
In this article: NVO, SNY, SVA, AMGN, GILD, ZLAB, TSRO
Read
Novo Nordisk (NVO) Beats On Q2 Earnings, Revenues Miss
Article By: Zacks Investment Research
Friday, August 11, 2017 3:00 PM EST
Novo Nordisk A/S NVO reported second-quarter 2017 earnings of 59 cents per American Depositary Receipt (ADR) beating the Zacks Consensus Estimate of 56 cents by 5.4%. In fact, the reported earnings were in line with the year ago figure.
In this article: NVO Also: ENZ, SNY, ADRO
Read

PARTNER HEADLINES

Latest Tweets for $NVO

No tweets yet!